We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
-24.42%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.44B
AUM Growth
-$733M
(-34%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-8.58%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
366
New
63
Increased
73
Reduced
132
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$42.5M |
| 2 |
Valvoline
VVV
|
+$33.1M |
| 3 |
Hershey
HSY
|
+$28.9M |
| 4 |
Avnet
AVT
|
+$27.6M |
| 5 |
Zurn Elkay Water Solutions
ZWS
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamar Advertising Co
LAMR
|
+$39.2M |
| 2 |
Huntington Bancshares
HBAN
|
+$34.7M |
| 3 |
Acushnet Holdings
GOLF
|
+$29.8M |
| 4 |
Jack in the Box
JACK
|
+$29M |
| 5 |
Verizon
VZ
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.82% |
| 2 | Financials | 17.59% |
| 3 | Industrials | 12.93% |
| 4 | Technology | 12.58% |
| 5 | Healthcare | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PennyMac Financial
PFSI
$4.42B
| $774K | 0.05% |
34,998
-2,114
| -6% | -$68K |
|
152
Iridium Communications
IRDM
$4.85B
| $763K | 0.05% |
+34,191
| New | +$885K |
|
|
XLRN
153
DELISTED
Acceleron Pharma
XLRN
| $751K | 0.05% |
+8,359
| New | +$650K |
|
154
Strategic Education
STRA
$1.77B
| $750K | 0.05% |
5,363
-7,381
| -58% | -$1.13M |
|
155
Moderna
MRNA
$22.1B
| $748K | 0.05% |
24,965
-13,957
| -36% | -$321K |
|
156
Vanguard Mid-Cap ETF
VO
$106B
| $725K | 0.05% |
+22,020
| New | +$912K |
|
157
Arvinas
ARVN
$534M
| $717K | 0.05% |
17,798
-13,204
| -43% | -$618K |
|
|
ENV
158
DELISTED
ENVESTNET, INC.
ENV
| $714K | 0.05% |
+13,280
| New | +$951K |
|
159
Domino's
DPZ
$11.5B
| $704K | 0.05% |
2,171
+1,018
| +88% | +$314K |
|
|
DCPH
160
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $697K | 0.05% |
16,918
+7,481
| +79% | +$415K |
|
161
AudioCodes
AUDC
$248M
| $694K | 0.05% |
29,051
-395
| -1% | -$9.16K |
|
162
Kodiak Sciences
KOD
$2.64B
| $693K | 0.05% |
14,525
-4,511
| -24% | -$271K |
|
|
INOV
163
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $689K | 0.05% |
41,348
+9,455
| +30% | +$179K |
|
164
Axalta
AXTA
$7.24B
| $664K | 0.05% |
38,470
-7,450
| -16% | -$191K |
|
165
Natera
NTRA
$37.3B
| $662K | 0.05% |
22,183
-13,462
| -38% | -$450K |
|
166
Twist Bioscience
TWST
$5.39B
| $658K | 0.05% |
+21,525
| New | +$579K |
|
167
Palomar
PLMR
$3.69B
| $646K | 0.04% |
+11,099
| New | +$580K |
|
|
HZNP
168
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $642K | 0.04% |
21,658
-23,105
| -52% | -$782K |
|
169
InMode
INMD
$890M
| $626K | 0.04% |
58,248
+35,194
| +153% | +$622K |
|
170
Tesla
TSLA
$1.22T
| $604K | 0.04% |
17,280
-13,965
| -45% | -$579K |
|
|
EQC.PRD
171
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $599K | 0.04% |
23,000
| – | – |
|
|
TPTX
172
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $594K | 0.04% |
13,294
-6,477
| -33% | -$344K |
|
173
RingCentral
RNG
$4.4B
| $584K | 0.04% |
2,758
+712
| +35% | +$147K |
|
|
YMAB
174
DELISTED
Y-mAbs Therapeutics
YMAB
| $584K | 0.04% |
22,391
-11,560
| -34% | -$336K |
|
175
CoStar Group
CSGP
$12.1B
| $577K | 0.04% |
9,820
-5,140
| -34% | -$335K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
RPAM
BBI
SSG
Advisory Research's Q1 2020 Portfolio in Review
As of Q1 2020, Advisory Research held 366 positions worth $1.44B, down 34% from $2.18B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Advisory Research withdrew a net $124M in Q1 2020, closing 88 positions and reducing 132 holdings. Its most notable exit was Lamar Advertising Co, an estimated $39.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
Against the trend, Advisory Research opened a new position in Hershey worth $26M.
- Advisory Research's largest Q1 2020 buy was Hershey: 196,008 shares worth $26M.
- Advisory Research added most to Microsoft in Q1 2020, an estimated $42.5M increase.
- Advisory Research's biggest Q1 2020 reduction was Verizon, cutting an estimated $27.8M.
- Advisory Research fully exited Lamar Advertising Co in Q1 2020, selling an estimated $39.2M.
- Advisory Research's ten largest holdings make up 26% of its $1.44B portfolio in Q1 2020.
- Advisory Research opened 63 new positions and closed 88 in Q1 2020.
- Advisory Research's portfolio value fell 34% quarter-over-quarter to $1.44B.
Based on Advisory Research's 13F filing for Q1 2020, filed 12 May 2020.